miR-299-3p suppresses cell progression and induces apoptosis by downregulating PAX3 in gastric cancer
Gastric cancer (GC) is ranked the fourth leading cause of cancer-related death, with an over 75% mortality rate worldwide. In recent years, miR-299-3p has been identified as a biomarker in multiple cancers, such as acute promyelocytic leukemia, thyroid cancer, and lung cancer. However, the regulator...
Enregistré dans:
Auteurs principaux: | Wang Zhenfen, Liu Qing, Huang Ping, Cai Guohao |
---|---|
Format: | article |
Langue: | EN |
Publié: |
De Gruyter
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/db7eeb1c2e1741b896d847ce81510c5f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Regulation of Pax7 protein levels by caspase-3 and proteasome activity in differentiating myoblasts
par: Olguín,Hugo C
Publié: (2011) -
Targeting Oncogenic miR-181a-2-3p Inhibits Growth and Suppresses Cisplatin Resistance of Gastric Cancer
par: Jin L, et autres
Publié: (2021) -
LncRNA LINC00483 promotes gastric cancer development through regulating MAPK1 expression by sponging miR-490-3p
par: Luo,Min, et autres
Publié: (2020) -
Expression of Pax6 and Pax7 Proteins During the Central Nervous System Development in Human Embryos
par: Namm,Aimar, et autres
Publié: (2020) -
The diagnostic and prognostic value of miR-92a in gastric cancer: A systematic review and meta-analysis
par: Guo Hanxu, et autres
Publié: (2021)